<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>observational cohort study &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/observational-cohort-study/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 16 Jan 2026 03:49:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>observational cohort study &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Sex Differences in Biomarkers and Memory Decline in Alzheimer’s</title>
		<link>https://bioengineer.org/sex-differences-in-biomarkers-and-memory-decline-in-alzheimers/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 03:49:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alzheimer’s biomarkers]]></category>
		<category><![CDATA[Early Alzheimer's disease]]></category>
		<category><![CDATA[Memory decline]]></category>
		<category><![CDATA[observational cohort study]]></category>
		<category><![CDATA[Sex differences in Alzheimer's]]></category>
		<guid isPermaLink="false">https://bioengineer.org/sex-differences-in-biomarkers-and-memory-decline-in-alzheimers/</guid>

					<description><![CDATA[Recent advancements in Alzheimer’s disease research have shed light on a compelling subject: the intricate relationship between sex differences and memory decline as measured by biomarker changes. A groundbreaking observational cohort study led by notable researchers Sundermann, Banks, and Bondi seeks to unravel these complexities, foregrounding the critical role that biological sex plays in the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317386</post-id>	</item>
		<item>
		<title>Impact of Screening History and Cancer Stage on Mortality in Screen-Detected Breast Cancer</title>
		<link>https://bioengineer.org/impact-of-screening-history-and-cancer-stage-on-mortality-in-screen-detected-breast-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 15 Apr 2025 15:22:25 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer screening impact]]></category>
		<category><![CDATA[ER-positive HER2-negative subtypes]]></category>
		<category><![CDATA[mortality reduction elderly women]]></category>
		<category><![CDATA[observational cohort study]]></category>
		<category><![CDATA[screening history cancer stage]]></category>
		<guid isPermaLink="false">https://bioengineer.org/impact-of-screening-history-and-cancer-stage-on-mortality-in-screen-detected-breast-cancer/</guid>

					<description><![CDATA[In a groundbreaking new cohort study published in JAMA Network Open, researchers have illuminated the pivotal role of routine screening mammography in altering the clinical landscape for older women diagnosed with specific subtypes of breast cancer. The study, focusing primarily on individuals with estrogen receptor–positive (ER-positive) and human epidermal growth factor receptor 2–negative (HER2-negative) breast [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">241050</post-id>	</item>
	</channel>
</rss>
